1. Home
  2. PEPG vs PED Comparison

PEPG vs PED Comparison

Compare PEPG & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEPG
  • PED
  • Stock Information
  • Founded
  • PEPG 2018
  • PED N/A
  • Country
  • PEPG United States
  • PED United States
  • Employees
  • PEPG N/A
  • PED N/A
  • Industry
  • PEPG Biotechnology: Pharmaceutical Preparations
  • PED Oil & Gas Production
  • Sector
  • PEPG Health Care
  • PED Energy
  • Exchange
  • PEPG Nasdaq
  • PED Nasdaq
  • Market Cap
  • PEPG 45.9M
  • PED 54.5M
  • IPO Year
  • PEPG 2022
  • PED N/A
  • Fundamental
  • Price
  • PEPG $1.49
  • PED $0.60
  • Analyst Decision
  • PEPG Buy
  • PED Strong Buy
  • Analyst Count
  • PEPG 3
  • PED 1
  • Target Price
  • PEPG $7.67
  • PED $1.50
  • AVG Volume (30 Days)
  • PEPG 335.1K
  • PED 117.3K
  • Earning Date
  • PEPG 11-06-2025
  • PED 08-14-2025
  • Dividend Yield
  • PEPG N/A
  • PED N/A
  • EPS Growth
  • PEPG N/A
  • PED 569.41
  • EPS
  • PEPG N/A
  • PED 0.14
  • Revenue
  • PEPG N/A
  • PED $35,334,000.00
  • Revenue This Year
  • PEPG N/A
  • PED N/A
  • Revenue Next Year
  • PEPG N/A
  • PED $17.41
  • P/E Ratio
  • PEPG N/A
  • PED $4.46
  • Revenue Growth
  • PEPG N/A
  • PED 3.93
  • 52 Week Low
  • PEPG $0.88
  • PED $0.47
  • 52 Week High
  • PEPG $10.06
  • PED $1.04
  • Technical
  • Relative Strength Index (RSI)
  • PEPG 64.86
  • PED 46.52
  • Support Level
  • PEPG $1.13
  • PED $0.58
  • Resistance Level
  • PEPG $1.32
  • PED $0.63
  • Average True Range (ATR)
  • PEPG 0.09
  • PED 0.02
  • MACD
  • PEPG 0.03
  • PED 0.00
  • Stochastic Oscillator
  • PEPG 87.80
  • PED 34.00

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: